<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dynavax Technologies Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dynavax Technologies Corporation

    Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. We develop immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology and its ability to modulate the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Robert L. Coffman, PhD
    • FOUNDED
      1996
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Rubius Therapeutics, Inc.

    Rubius Therapeutics, Inc.

    Rubius Therapeutics developed our proprietary RED PLATFORMÂŽ to generate red blood...

    Rubius Therapeutics developed our proprietary R...

    Filing Type:    PU
    Enflux, Inc.

    Enflux, Inc.

    We make getting back relief more convenient, inexpensive, and more fun. BackAlert ...

    We make getting back relief more convenient, in...

    Amount Raised:    $11,741.00
    Fundraising Status:    EC
    Filing Type:    CF
    Maternova, Inc.

    Maternova, Inc.

    Maternova, Inc. is the trusted resource for cutting edge medical innovations in ne...

    Maternova, Inc. is the trusted resource for cut...

    Amount Raised:    $104,976.00
    Fundraising Status:    EC
    Filing Type:    CF
    VIVUS, Inc.

    VIVUS, Inc.

    With demonstrated clinical development and commercialization expertise, VIVUS is d...

    With demonstrated clinical development and comm...

    Filing Type:    PU
    Atossa Genetics Inc.

    Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical...

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is...

    Filing Type:    PU
    Emerald Health Pharmaceuticals Inc

    Emerald Health Pharmaceuticals Inc

    Emerald Health Pharmaceuticals (EHP) combines decades of life science and drug dev...

    Emerald Health Pharmaceuticals (EHP) combines d...

    Amount Raised:    11.600,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...

    G1 Therapeutics, Inc., is a clinical-stage biop...

    Filing Type:    PU
    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc. an early stage digital diagnostics company with the core m...

    20/20 GeneSystems, Inc. an early stage digital ...

    Fundraising Status:    SASBEC
    Filing Type:    RA
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...

    Concert Pharmaceuticals is a clinical stage bio...

    Filing Type:    PU
    Midatech Pharma PLC

    Midatech Pharma PLC

    Midatech is an international specialty pharmaceutical company focused on the devel...

    Midatech is an international specialty pharmace...

    Filing Type:    PU
    Galapagos NV

    Galapagos NV

    Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, ...

    Galapagos develops therapies with proprietary, ...

    Filing Type:    PU
    ChemoCentryx, Inc.

    ChemoCentryx, Inc.

    ChemoCentryx is a biopharmaceutical company focused exclusively on discovering, de...

    ChemoCentryx is a biopharmaceutical company foc...

    Filing Type:    PU
    Apellis Pharmaceuticals, Inc.

    Apellis Pharmaceuticals, Inc.

    We are a clinical-stage biopharmaceutical company focused on the development of no...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.